Share-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2026

Share-Based Payment Arrangement [Abstract]

Summary of Fair Value of MRI EICP Options and Valuation Assumptions

The fair value of the MRI EICP options was estimated using the Black-Scholes option pricing model. The following table provides the weighted-average option assumptions (no dividends were expected):



		April 2023 Awards
Options awarded			2,100,000
Risk-free interest rate		3.71%-3.97%
Expected volatility		78%-80%
Expected option life (in years)		3.5-5.5
Grant-date fair value		$	4.25

		January 2021 Awards
Options awarded			950,214
Risk-free interest rate		0.5%
Expected volatility		32%
Expected option life (in years)			5.5
Grant-date fair value		$	3.44

Summary of Outstanding Activity of Options, Restricted Stock and Restricted Stock Units under MRI EICP

The following table summarizes the restricted shares, restricted stock units and options outstanding under the MRI EICP as of March 31, 2026 and 2025, respectively:



		Restricted Shares								Restricted Stock Units								Options
		Number of shares				Weighted Average Grant Date Fair Value				Number of shares				Weighted Average Grant Date Fair Value				Number of shares				Weighted Average Exercise Price
End of period - December 31, 2024			626,108			$	11.93				170,000			$	7.63				2,325,000			$	7.04
Beginning of period - January 1, 2025			626,108			$	11.93				170,000			$	7.63				2,325,000			$	7.04
Granted			—				—				—				—				—				—
Vested			—				—				—				—				—				—
End of period - Balance at March 31, 2025			626,108			$	11.93				170,000			$	7.63				2,325,000			$	7.04

End of period - December 31, 2025			—			$	—				130,000			$	4.97				2,100,000			$	6.77
Beginning of period - January 1, 2026			—			$	—				130,000			$	4.97				2,100,000			$	6.77
Granted			—			—					—				—				—				—
Vested			—				—				—				—				—				—
Forfeited			—				—				—				—				—			—
End of period - March 31, 2026			—			$	—				130,000			$	4.97				2,100,000			$	6.77